Literature DB >> 16793390

RAG and HMGB1 proteins: purification and biochemical analysis of recombination signal complexes.

Serge Bergeron1, Dirk K Anderson, Patrick C Swanson.   

Abstract

Two lymphoid cell-specific proteins, called RAG-1 and RAG-2, initiate the process of antigen receptor gene rearrangement, termed V(D)J recombination, by assembling a protein-DNA complex with two recombination signal sequences (RSSs), each of which adjoins a different receptor gene segment, and then introducing a DNA double strand break at the end of each RSS. The study of RAG-RSS complex assembly and activity has been facilitated by the development of methods to purify the RAG proteins and members of the HMG-box family of high mobility group proteins such as HMGB1 that promote RAG binding and cleavage activity in vitro. This chapter describes the purification of recombinant truncated and full-length RAG-1 and RAG-2 expressed transiently in mammalian cells, as well as the purification of bacterially expressed full-length HMGB1. In addition, it details several experimental procedures used in our laboratory to study RAG-RSS complex formation and function in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793390     DOI: 10.1016/S0076-6879(06)08032-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  30 in total

1.  Mechanistic basis for RAG discrimination between recombination sites and the off-target sites of human lymphomas.

Authors:  Noriko Shimazaki; Amjad Askary; Patrick C Swanson; Michael R Lieber
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Identification and characterization of a gain-of-function RAG-1 mutant.

Authors:  Aleksei N Kriatchko; Dirk K Anderson; Patrick C Swanson
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

3.  A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement.

Authors:  Yun Liu; Ramesh Subrahmanyam; Tirtha Chakraborty; Ranjan Sen; Stephen Desiderio
Journal:  Immunity       Date:  2007-10-11       Impact factor: 31.745

Review 4.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

5.  Mapping and Quantitation of the Interaction between the Recombination Activating Gene Proteins RAG1 and RAG2.

Authors:  Yu-Hang Zhang; Keerthi Shetty; Marius D Surleac; Andrei J Petrescu; David G Schatz
Journal:  J Biol Chem       Date:  2015-03-05       Impact factor: 5.157

6.  A novel RAG1 mutation reveals a critical in vivo role for HMGB1/2 during V(D)J recombination.

Authors:  Daniel T Thwaites; Clive Carter; Dylan Lawless; Sinisa Savic; Joan M Boyes
Journal:  Blood       Date:  2018-12-11       Impact factor: 22.113

7.  H3K4me3 induces allosteric conformational changes in the DNA-binding and catalytic regions of the V(D)J recombinase.

Authors:  John Bettridge; Chan Hyun Na; Akhilesh Pandey; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

8.  Fluorescence resonance energy transfer analysis of recombination signal sequence configuration in the RAG1/2 synaptic complex.

Authors:  Mihai Ciubotaru; Aleksei N Kriatchko; Patrick C Swanson; Frank V Bright; David G Schatz
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

9.  Vitamin C promotes maturation of T-cells.

Authors:  Jared Manning; Birgitta Mitchell; Daniel A Appadurai; Arvind Shakya; Laura Jean Pierce; Hongfang Wang; Vincent Nganga; Patrick C Swanson; James M May; Dean Tantin; Gerald J Spangrude
Journal:  Antioxid Redox Signal       Date:  2013-02-05       Impact factor: 8.401

10.  Structure of the RAG1 nonamer binding domain with DNA reveals a dimer that mediates DNA synapsis.

Authors:  Fang Fang Yin; Scott Bailey; C Axel Innis; Mihai Ciubotaru; Satwik Kamtekar; Thomas A Steitz; David G Schatz
Journal:  Nat Struct Mol Biol       Date:  2009-04-26       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.